1. Home
  2. ANIX vs AMTX Comparison

ANIX vs AMTX Comparison

Compare ANIX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.95

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.42

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
AMTX
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
98.6M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
ANIX
AMTX
Price
$2.95
$1.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.00
$17.00
AVG Volume (30 Days)
141.7K
828.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
$77,194,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$139.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
174.60
52 Week Low
$2.33
$1.22
52 Week High
$5.46
$3.66

Technical Indicators

Market Signals
Indicator
ANIX
AMTX
Relative Strength Index (RSI) 45.34 42.92
Support Level $2.69 $1.38
Resistance Level $3.00 $1.65
Average True Range (ATR) 0.17 0.08
MACD 0.03 -0.01
Stochastic Oscillator 70.42 11.63

Price Performance

Historical Comparison
ANIX
AMTX

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: